Form 4 Filing for IMMUNIC, INC. - Vitt Daniel

Vitt Daniel, a director at IMMUNIC, INC., acquired 445,000 stock options on June 29, 2026. These options, representing the right to purchase common stock, were granted with a nominal price of $0.00. The options are subject to the approval of an amendment to the Company's 2019 Omnibus Equity Incentive Plan, which was obtained at the 2026 Annual Meeting of Stockholders. The underlying shares vest over a period of 37 months, starting with 25% on April 2, 2027, and the remainder in equal monthly increments thereafter. The exercise price for these options is $11.60 per share, with an expiration date of April 2, 2036. This transaction is reported on a Form 4 filing.